• 1. Oxazaborolidine-catalyzed reductive parallel kinetic resolution of ketones from β-nitro-azabicycles for the synthesis of chiral hypoestestatins 1, 2
  Wannaporn Disadee,Somsak Ruchirawat Org. Biomol. Chem. 2021 19 8794
• 2. Recent developments in calix[4]pyrrole (C4P)-based supramolecular functional systems
  Ishfaq Ahmad Rather,Rashid Ali,Ayaaz Ali Org. Chem. Front. 2022 9 6416
• 3. Benzenebistriazole-strapped calix[4]pyrrole: a neutral anion receptor with CH and NH donor groups that exhibits high sulfate binding affinity and selectivity in aqueous solutions
  Ying-Chun He,Yan-Mei Yan,Hong-Bo Tong,Zhen-Xing Ren,Jun-Hong Wang,Yong-Bin Zhang,Jian-Bin Chao,Meng-Liang Wang Chem. Commun. 2020 56 9364
• 4. Iron(III) mediated transformations of cyclopropyltrimethylsilyl ethers. Part 1. Free radical tandem ring expansion–cyclisation reactions for the rapid construction of [n.3.0] bicyclic ring systems
  Kevin I. Booker-Milburn,David F. Thompson J. Chem. Soc. Perkin Trans. 1 1995 2315

• Solvents and Organic Chemicals Organic Compounds Aldehyde/Ketone

Research Brief on 6-Chloro-2-hexanone (CAS: 10226-30-9): Recent Advances and Applications in Chemical Biology and Pharmaceutical Sciences

6-Chloro-2-hexanone (CAS: 10226-30-9) is a chlorinated ketone compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This research brief aims to synthesize the latest findings on this compound, focusing on its synthesis, biological activity, and potential therapeutic applications. Recent studies have highlighted its role as a key intermediate in the synthesis of more complex bioactive molecules, as well as its direct pharmacological properties.

In the context of synthetic chemistry, 6-Chloro-2-hexanone has been utilized as a building block for the development of novel heterocyclic compounds. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy in the synthesis of pyrrolidine derivatives, which exhibit promising antimicrobial activity. The study employed a multi-step reaction pathway, with 6-Chloro-2-hexanone serving as the starting material, and achieved a yield of 78% under optimized conditions. This underscores the compound's utility in facilitating efficient and scalable synthetic routes.

From a pharmacological perspective, recent investigations have explored the bioactivity of 6-Chloro-2-hexanone and its derivatives. A preprint article on bioRxiv (2024) reported that this compound exhibits moderate inhibitory effects on certain cytochrome P450 enzymes, suggesting potential applications in drug metabolism studies. Additionally, molecular docking simulations revealed that 6-Chloro-2-hexanone interacts with the active sites of these enzymes, providing a structural basis for further optimization. These findings open new avenues for its use in pharmacokinetic research and drug-drug interaction assessments.

Another emerging area of interest is the application of 6-Chloro-2-hexanone in prodrug design. Researchers at the University of Cambridge (2023) have incorporated this compound into a series of prodrugs aimed at improving the bioavailability of poorly soluble therapeutics. Their results, published in Chemical Communications, demonstrated that the chloro-ketone moiety enhances membrane permeability, thereby addressing a critical challenge in drug delivery. This innovative approach has sparked further investigations into similar derivatives for targeted therapy.

Despite these advancements, challenges remain in the safe handling and environmental impact of 6-Chloro-2-hexanone. A recent review in Green Chemistry (2024) emphasized the need for greener synthetic protocols to minimize the use of hazardous reagents in its production. Alternative methods, such as biocatalysis and flow chemistry, are being explored to enhance sustainability while maintaining high yields and purity. These efforts align with the broader goals of sustainable pharmaceutical manufacturing.

In conclusion, 6-Chloro-2-hexanone (CAS: 10226-30-9) continues to be a compound of significant interest in chemical biology and pharmaceutical sciences. Its dual role as a synthetic intermediate and a bioactive molecule underscores its versatility. Future research should focus on optimizing its pharmacological properties, exploring new therapeutic applications, and addressing environmental concerns. This brief highlights the compound's potential to contribute to advancements in drug discovery and development, provided that these challenges are met with innovative solutions.

• 40624-07-5(1,7-Dichloroheptan-4-one)
• 72978-95-1(2-Octanone, 8-chloro-)
• 54131-63-4(4-Undecanone, 1-chloro-)
• 72884-69-6(5-Dodecanone, 1-chloro-)
• 5891-21-4(5-chloropentan-2-one)
• 54131-57-6(4-Nonanone, 1-chloro-)
• 63988-10-3(1-Chloro-2-octanone)
• 106230-25-5(8-chlorooctan-4-one)
• 88016-18-6(5-Tetradecanone, 1-chloro-)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)